Last updated: December 12, 2022
Sponsor: N/A
Overall Status: Active - Recruiting
Phase
2
Condition
Asthma
Treatment
N/AClinical Study ID
TX291177
D7552C00001
Ages 18-55 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- be 18 to 55 years of age
- have moderate to severe uncontrolled asthma
- have documented diagnosis of asthma 12 months prior to screening visit
Exclusion
Exclusion Criteria:
- A severe asthma exacerbation within 8 weeks of randomization.
- Participants with a significant COVID-19 illness within 6 months of enrollment:
- Participants with a diagnosis of COVID-19 pneumonia based on radiological assessment
- Participants with a diagnosis of COVID-19 requiring hospitalization and/or oxygen supplementation therapy
- Galactose intolerance, Lapp lactase deficiency, or glucose-galactose metabolism
Study Design
Study Start date:
Estimated Completion Date:
Study Description
Connect with a study center
AMR Lexington
Lexington, Kentucky 40509
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.